145 related articles for article (PubMed ID: 21424114)
1. Comprehensive gene expression microarray analysis of Ets-1 blockade in PC3 prostate cancer cells and correlations with prostate cancer tissues: Insights into genes involved in the metastatic cascade.
Adler D; Lindstrot A; Langer B; Buettner R; Wernert N
Int J Mol Med; 2011 Jun; 27(6):811-9. PubMed ID: 21424114
[TBL] [Abstract][Full Text] [Related]
2. Ets-1 is implicated in the regulation of androgen co-regulator FHL2 and reveals specificity for migration, but not invasion, of PC3 prostate cancer cells.
Adler D; Langer B; Lindstrot A; Florin A; Bosserhoff A; Buettner R; Wernert N
Oncol Rep; 2011 Apr; 25(4):1125-9. PubMed ID: 21258770
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of ETS family members in prostate cancer tissues and androgen-sensitive and insensitive prostate cancer cell lines.
Adler D; Lindstrot A; Langer B; Buettner R; Wernert N
Int J Mol Med; 2011 Jul; 28(1):89-93. PubMed ID: 21491078
[TBL] [Abstract][Full Text] [Related]
4. Regulation of prostate cancer immunity-related genes in PC3 prostate cancer cells by ETS-1.
Adler D; Lindstrot A; Buettner R; Wernert N
Oncol Lett; 2012 Mar; 3(3):513-516. PubMed ID: 22740941
[TBL] [Abstract][Full Text] [Related]
5. Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.
Chakrabarti R; Robles LD; Gibson J; Muroski M
Cancer Genet Cytogenet; 2002 Dec; 139(2):115-25. PubMed ID: 12550771
[TBL] [Abstract][Full Text] [Related]
6. Genes differentially expressed in the peripheral zone compared to the transitional zone of the normal human prostate and their potential regulation by ETS factors.
Adler D; Lindstrot A; Ellinger J; Rogenhofer S; Buettner R; Wernert N
Mol Med Rep; 2012 Jan; 5(1):32-6. PubMed ID: 21993862
[TBL] [Abstract][Full Text] [Related]
7. Gene expression analysis of human prostate cell lines with and without tumor metastasis suppressor CD82.
Dodla P; Bhoopalan V; Khoo SK; Miranti C; Sridhar S
BMC Cancer; 2020 Dec; 20(1):1211. PubMed ID: 33298014
[TBL] [Abstract][Full Text] [Related]
8. Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression.
Dozmorov MG; Azzarello JT; Wren JD; Fung KM; Yang Q; Davis JS; Hurst RE; Culkin DJ; Penning TM; Lin HK
BMC Cancer; 2010 Dec; 10():672. PubMed ID: 21134280
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiles of I3C- and DIM-treated PC3 human prostate cancer cells determined by cDNA microarray analysis.
Li Y; Li X; Sarkar FH
J Nutr; 2003 Apr; 133(4):1011-9. PubMed ID: 12672912
[TBL] [Abstract][Full Text] [Related]
10. [Screening of phosphoprotein associated with glycosphingolipid microdomains 1 (PAG1) by cDNA microarray and influence of overexpression of PAG1 on biologic behavior of human metastatic prostatic cancer cell line in vitro].
Yu WJ; Wang YW; Xie ZG; You JF; Wang JL; Cui XL; Pei F; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2010 Feb; 39(2):88-94. PubMed ID: 20388373
[TBL] [Abstract][Full Text] [Related]
11. Novel identification of the ETS-1 splice variants p42 and p27 in prostate cancer cell lines.
Adler D; Ochsenfahrt J; Fuchs K; Wernert N
Oncol Rep; 2012 May; 27(5):1321-4. PubMed ID: 22307076
[TBL] [Abstract][Full Text] [Related]
12. Changes in gene expression induced by phosphorothioate oligodeoxynucleotides (including G3139) in PC3 prostate carcinoma cells are recapitulated at least in part by treatment with interferon-beta and -gamma.
Benimetskaya L; Wittenberger T; Stein CA; Hofmann HP; Weller C; Lai JC; Miller P; Gekeler V
Clin Cancer Res; 2004 Jun; 10(11):3678-88. PubMed ID: 15173074
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiles of genistein-treated PC3 prostate cancer cells.
Li Y; Sarkar FH
J Nutr; 2002 Dec; 132(12):3623-31. PubMed ID: 12468598
[TBL] [Abstract][Full Text] [Related]
14. Identification of immunity-related genes in prostate cancer and potential role of the ETS family of transcription factors in their regulation.
Adler D; Lindstrot A; Ellinger J; Rogenhofer S; Buettner R; Wernert N
Int J Mol Med; 2011 Nov; 28(5):799-807. PubMed ID: 21833467
[TBL] [Abstract][Full Text] [Related]
15. A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells.
Yamanaka K; Rocchi P; Miyake H; Fazli L; Vessella B; Zangemeister-Wittke U; Gleave ME
Mol Cancer Ther; 2005 Nov; 4(11):1689-98. PubMed ID: 16275990
[TBL] [Abstract][Full Text] [Related]
16. ERG upregulation and related ETS transcription factors in prostate cancer.
Rostad K; Mannelqvist M; Halvorsen OJ; Oyan AM; Bø TH; Stordrange L; Olsen S; Haukaas SA; Lin B; Hood L; Jonassen I; Akslen LA; Kalland KH
Int J Oncol; 2007 Jan; 30(1):19-32. PubMed ID: 17143509
[TBL] [Abstract][Full Text] [Related]
17. Analysis of differentially expressed genes in LNCaP prostate cancer progression model.
Xie BX; Zhang H; Wang J; Pang B; Wu RQ; Qian XL; Yu L; Li SH; Shi QG; Huang CF; Zhou JG
J Androl; 2011; 32(2):170-82. PubMed ID: 20864652
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein.
Li Y; Sarkar FH
Cancer Lett; 2002 Dec; 186(2):157-64. PubMed ID: 12213285
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling reveals novel targets of estramustine phosphate in prostate cancer cells.
Hong X; Li Y; Hussain M; Sarkar FH
Cancer Lett; 2004 Jun; 209(2):187-95. PubMed ID: 15159021
[TBL] [Abstract][Full Text] [Related]
20. ETS transcription factors and prostate cancer: the role of the family prototype ETS-1 (review).
Adler D; Wernert N
Int J Oncol; 2012 Jun; 40(6):1748-54. PubMed ID: 22366814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
